Congenital enterovirus infection happens when a baby catches enterovirus before birth or soon after delivery. Newborns can have fever, poor feeding, sleepiness, rash, or trouble breathing, and doctors may see signs like low blood pressure or swollen liver. Symptoms can start in the first days of life and may progress quickly, but many babies recover with timely care. Treatment focuses on supportive care in the hospital, such as fluids, oxygen, and close monitoring, and some receive antiviral or immune-based therapies. Not everyone will have the same experience, and outcomes range from mild illness to severe disease, with higher risk in very young or preterm infants.
Overview
Congenital enterovirus infectionSymptoms
Early signs of congenital enterovirus infection in newborns include fever, poor feeding, irritability, sleepiness, rash, or breathing trouble. Severe signs may include seizures, jaundice, enlarged liver, bleeding problems, or inflammation of the heart or brain soon after birth.
Outlook and prognosis
Most babies with congenital enterovirus infection recover fully with careful hospital support and follow‑up. Severe illness—such as heart, brain, or liver involvement—can lead to complications, and outcomes vary with how early treatment starts. Regular pediatric and specialist visits guide long‑term health.
Causes and risk factors
Congenital enterovirus infection occurs when fetus is exposed after maternal infection during pregnancy or at delivery.
Risk increases with maternal infection, illness late in pregnancy, lack of maternal antibodies, seasonal outbreaks, poor hand hygiene, and prematurity.
No known genetic predisposition.
Genetic influences
Genetics plays a limited role in congenital enterovirus infection. The virus causes the illness; inherited differences mainly influence how strongly the immune system responds. Rare immune gene variants can increase risk for severe disease, but most cases aren’t genetically driven.
Diagnosis
Doctors suspect congenital enterovirus infection from newborn clinical features and maternal illness around delivery. Diagnosis of congenital enterovirus infection relies on PCR testing of blood, cerebrospinal fluid, or throat/stool samples, plus supportive labs. Imaging or echocardiography may assess complications.
Treatment and drugs
Treatment for congenital enterovirus infection focuses on supportive care—fluids, nutrition, and careful monitoring of breathing, heart, and liver function. Newborns with severe disease may receive antiviral therapy (such as pleconaril where available) and immune globulin. Care often involves neonatal intensive care, infection control, and follow‑up for hearing, heart, or developmental concerns.
Symptoms
In the first days of life, babies with congenital enterovirus infection may seem off—feeding less, fussier, or sleepier than expected. You might notice small changes at first, but they can add up quickly. Some early features of congenital enterovirus infection overlap with common newborn issues, yet the infection can sometimes involve the brain, heart, liver, skin, or lungs. Signs can range from mild to severe and may change over hours to days.
Babies may feed slowly, take less milk, or have a weak latch. More spit-up or vomiting after feeds can show up. These changes can be part of congenital enterovirus infection.
A baby may be unusually sleepy, hard to wake, or floppy; others are very fussy and hard to console. These patterns can shift over a single day.
A rectal temperature of 38.0°C (100.4°F) or higher can signal infection; some babies get cold instead, below about 36.5°C (97.7°F). Warm or cool skin, sweating, or chills may appear. Both fever and low temperature can occur with congenital enterovirus infection.
Small red spots, tiny pinpoint dots, or clear blisters can appear on the skin. They may be scattered or form clusters on the trunk, arms, legs, palms, or soles. A rash can be among the early features of congenital enterovirus infection.
How people usually first notice Congenital enterovirus infection?
Congenital enterovirus infection is usually first noticed around birth or in the first days of life when a newborn develops fever, poor feeding, unusual sleepiness, or rapid breathing that seems out of proportion to a typical newborn adjustment. Doctors and families may also see a blotchy rash, irritability, or signs that specific organs are affected, such as jaundice (yellow skin/eyes), an enlarged liver, low blood sugar, or seizures; in more severe cases, there can be heart inflammation with fast heart rate or poor circulation. Sometimes the first signs of congenital enterovirus infection appear on routine checks when blood tests show low platelets or liver enzyme changes, or when a baby exposed late in pregnancy becomes suddenly unwell in the first 1–2 weeks.
Types of Congenital enterovirus infection
Congenital enterovirus infection can look different from baby to baby, depending on when infection occurred in pregnancy or around birth, and which enterovirus is involved. Symptoms don’t always look the same for everyone. Clinicians often describe them in these categories: infections that start before birth, those acquired in the first weeks of life, and severe forms that affect certain organs like the heart, brain, or liver. When people ask about types of congenital enterovirus infection, they often mean these clinical patterns rather than different virus strains.
Intrauterine infection
Infection starts before birth and may show up at delivery with low energy, poor feeding, or breathing trouble. Doctors may see skin rash, enlarged liver or spleen, or low platelets on exam. Early symptoms of congenital enterovirus infection in this group can be subtle at first and then progress quickly.
Perinatal infection
Infection occurs late in pregnancy, during delivery, or within the first month. Babies often develop fever, irritability, or feeding problems within days to two weeks. Some progress to sepsis-like illness with low blood pressure and need hospital care.
Cardiac-predominant disease
The virus targets the heart, leading to myocarditis or heart failure signs. You may see fast breathing, sweating with feeds, or swelling from fluid buildup. Doctors may detect an enlarged heart or abnormal rhythms on testing.
Neurologic-predominant disease
The brain and coverings are affected, causing meningitis or encephalitis. Babies can be very sleepy, irritable with high-pitched cry, or have seizures. Spinal fluid tests and brain imaging help confirm the pattern.
Hepatic-predominant disease
The liver bears the brunt, with jaundice, easy bruising, or bleeding from clotting problems. Lab tests may show very high liver enzymes and low clotting factors. This form can overlap with a sepsis-like picture and needs urgent support.
Sepsis-like syndrome
Widespread infection causes fever or low temperature, poor perfusion, and breathing problems. For many, certain types stand out more than others. Blood tests, cultures, and viral testing guide care while doctors support blood pressure and oxygenation.
What genetics can tell you about symptoms
Some congenital enterovirus infections linked to specific viral strains or host immune‑gene differences can cause fever, poor feeding, irritability, and a sepsis‑like illness in newborns. Certain variations in innate immunity genes may raise risks of myocarditis, hepatitis, brain inflammation, or prolonged illness.
Causes and risk factors
Congenital enterovirus infection usually happens when a pregnant person gets an enterovirus close to delivery and the virus passes to the baby before or during birth. The risk is highest with a first-time infection late in pregnancy, because there is little time to transfer protective antibodies to the baby. Risk factors for congenital enterovirus infection include summer or early autumn circulation and close contact with sick siblings or hospital exposures around delivery. Babies born early or with low birth weight are more vulnerable, and inherited causes are not typical unless the baby has a serious immune problem. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
Congenital enterovirus infection happens when a baby is exposed to an enterovirus before birth, usually because the mother gets infected during pregnancy. Doctors often group risks into internal (biological) and external (environmental). Understanding these risks can help explain why early symptoms of congenital enterovirus infection may show up in the first days of life.
Enterovirus illness during pregnancy can put the virus into the pregnant person’s bloodstream. From there, it can cross the placenta and lead to congenital enterovirus infection.
Infection in the last weeks of pregnancy raises the chance that the baby is exposed before or during birth. Congenital enterovirus infection is more likely when illness occurs right before delivery.
When the amount of virus in the pregnant person’s blood is high, passage across the placenta becomes more likely. This increases the baby’s exposure in the womb.
If the pregnant person lacks antibodies to that enterovirus type, the virus can circulate longer in the blood. With less immune protection, the placenta may face more viral exposure.
Genetic risk factors
While a virus is the direct cause, inherited differences in the immune system can raise the chance of infection before birth or make illness more severe in a newborn. Some risk factors are inherited through our genes. These genetic risk factors for congenital enterovirus infection mainly affect how the body makes antibodies or switches on early antiviral alarms. Rare, single-gene conditions can play a role in the baby or, less often, the pregnant parent.
X-linked agammaglobulinemia: This inherited condition leaves the body with very low or absent antibodies. Without antibody protection, enteroviruses can spread widely and cause severe illness, sometimes including congenital enterovirus infection.
Severe antibody defects: Genetic forms of absent or very low antibodies (for example, autosomal agammaglobulinemia or some hyper-IgM conditions) reduce the body’s ability to neutralize enteroviruses. This can lead to more severe or persistent infection in early life.
Severe combined immunodeficiency: SCID disrupts both T-cell and B-cell function from birth. With these defenses impaired, enteroviruses can disseminate quickly and cause life-threatening disease in infants.
Type I interferon defects: Inherited problems in this early antiviral signaling pathway weaken the body’s first response to viral invasion. When exposed to enterovirus in the womb or shortly after birth, babies with these defects can develop rapid, severe illness.
Viral RNA sensing defects: Rare changes in genes that detect viral RNA (such as MDA5/IFIH1 or related pathways) can blunt the alarm that normally limits enterovirus replication. This increases the risk of widespread infection affecting organs like the heart or brain.
Maternal immune deficiency: If the pregnant parent has an inherited antibody or interferon disorder, the virus may linger longer in the bloodstream, increasing the chance it reaches the fetus. Lower maternal antibodies can also mean less transferred protection before birth.
Family history clues: Several relatives with early, severe viral infections or low antibody levels may signal an inherited immune condition in the family. In such families, a newborn may face higher risk from congenital enterovirus infection if exposure occurs.
Lifestyle risk factors
Lifestyle habits do not cause Congenital enterovirus infection, but day-to-day care can influence recovery, symptom burden, and complications. This overview focuses on how lifestyle affects Congenital enterovirus infection through feeding, hygiene, rest, and care routines. Choices that reduce new viral exposures and lower physiologic stress can help protect the heart, liver, and brain during healing.
Caregiver handwashing and surface cleaning reduce fecal-oral and respiratory enterovirus spread to the newborn. Fewer new exposures lower viral load pressure and the risk of relapse or co-infections.
Avoiding ill visitors and crowded settings decreases chances of acquiring additional enteroviruses. Preventing new infections protects vulnerable organs like the heart, liver, and brain during recovery.
Frequent, adequate feeds maintain glucose and fluid balance, easing stress on the liver and heart. Breast milk’s antibodies may help neutralize enteroviruses and support mucosal immunity.
Giving prescribed treatments (such as antipyretics, heart or liver support meds) exactly as directed helps control symptoms. Consistent dosing limits rebounds in fever, discomfort, and cardiac workload.
Risk prevention
For families, prevention focuses on lowering a pregnant person’s exposure to enteroviruses and protecting the newborn in the first weeks of life. Prevention is about lowering risk, not eliminating it completely. There’s no vaccine for most non-polio enteroviruses, so hygiene and smart contact rules matter most. If you’re pregnant or caring for a newborn at times of community outbreaks, extra caution can help reduce the chance of congenital enterovirus infection.
Wash with soap and water for at least 20 seconds after diaper changes, toilet use, and before feeding. Alcohol gel helps, but soap-and-water is better for germs that spread through the stool route.
Avoid close contact with people who have colds, fever, diarrhea, or mouth sores, especially in late pregnancy and the newborn period. Ask visitors to postpone if they’re unwell.
If you develop fever or viral symptoms near delivery, tell your maternity team promptly. They may adjust newborn precautions to lower the risk of congenital enterovirus infection.
Human milk provides antibodies that may help protect newborns from severe illness. If you’re ill, continue breastfeeding if you can while using strict hand hygiene and a mask during close contact.
Transmission
Congenital enterovirus infection happens when a baby picks up an enterovirus from their pregnant parent before birth or right around delivery. If you’re wondering how congenital enterovirus infection is transmitted, it usually occurs in late pregnancy when the virus is in the parent’s bloodstream and crosses the placenta, or during birth through contact with birth fluids, including stool. In the first days of life, some babies also become infected through close contact with caregivers who are carrying and spreading the virus, especially via unwashed hands after diaper changes or from coughs and sneezes. Enteroviruses spread easily—many adults have mild or no symptoms yet can pass them on—and the risk to a newborn is highest if the parent’s infection happens in the week before delivery. Congenital enterovirus infection is uncommon, but the viruses themselves are highly contagious.
When to test your genes
Consider genetic testing if a close relative had severe congenital enterovirus infection or unexplained neonatal illness, especially after a pregnancy or newborn course complicated by severe viral disease. Testing may uncover immune pathway variants that raise risk and guide targeted antivirals, immunoglobulin use, or vaccine planning. Discuss timing preconception, during pregnancy, or after an affected birth.
Diagnosis
Diagnosis of congenital enterovirus infection focuses on signs in the newborn and tests that directly detect the virus. Doctors look at how symptoms start in the first days of life and how quickly they progress, then choose targeted tests. Finding out the cause is the first step toward treatment. Results from different samples often come together to give a clear answer.
Clinicians check for fever, rash, poor feeding, sleepiness, breathing problems, jaundice, or a sepsis-like picture in the first 1–2 weeks of life. They also look for enlarged liver, low blood pressure, or irritability that can suggest serious infection.
A detailed family and health history can help identify possible exposure late in pregnancy or around delivery. Recent maternal fever, sore throat, or a household viral illness can raise suspicion for enterovirus.
Real-time PCR on blood, spinal fluid, throat or nasal swabs, and stool looks for enterovirus genetic material. Testing more than one sample type increases the chance of detection, especially early in illness.
Doctors may perform a lumbar puncture when meningitis or encephalitis is suspected. Cell counts, protein, and glucose are checked, and PCR on spinal fluid can confirm enterovirus in the nervous system.
Stages of Congenital enterovirus infection
Congenital enterovirus infection does not have defined progression stages. It’s an acute infection in newborns that can vary widely in severity and may change quickly, so care teams describe it by which organs are affected rather than by stepwise stages. Diagnosis usually starts with the early symptoms of congenital enterovirus infection—such as fever, poor feeding, unusual sleepiness, rash, or trouble breathing—and lab tests like a blood or spinal fluid test and gentle swabs to detect the virus (PCR). Different tests may be suggested to help confirm the diagnosis and check how organs like the heart, liver, and brain are doing.
Outlook and prognosis
Looking at day-to-day life, the course of congenital enterovirus infection depends a lot on how severe the illness is in the first days and weeks after birth. Everyone’s journey looks a little different. Babies with only mild early symptoms of congenital enterovirus infection—such as brief fever or mild feeding issues—often recover fully and do well long term, especially with careful monitoring during the newborn period. In contrast, when the virus affects the heart, brain, liver, or causes sepsis in the neonatal period, the risk of complications is higher and care in a neonatal intensive care unit is common.
Prognosis refers to how a condition tends to change or stabilize over time. When the infection is limited and treated with supportive care promptly, many infants have a good outlook and typical development. Severe illness can carry short-term mortality, particularly with myocarditis (heart inflammation), overwhelming sepsis, or liver failure; outcomes improve with early recognition, respiratory and blood pressure support, and, in select cases, antiviral or immunoglobulin therapy. Survivors of severe disease may face longer-term issues, such as developmental delays, seizures after neonatal meningoencephalitis, or heart rhythm problems after myocarditis, so scheduled follow-up with pediatrics, cardiology, and neurology is important.
With ongoing care, many people maintain healthy growth and development after congenital enterovirus infection, and families can expect the picture to become clearer over the first year as clinicians track feeding, growth, movement, and learning. Early care can make a real difference, including quick evaluation of new fevers, careful vaccination planning with your pediatrician, and early referral to developmental services if concerns arise. Talk with your doctor about what your personal outlook might look like, including warning signs that need urgent care and a plan for regular check-ins during infancy and beyond.
Long-term effects
For many families, the long-term picture after congenital enterovirus infection depends on how severe the illness was at birth and which organs were affected. Long-term effects vary widely, and some children have few or no lasting issues. Outcomes depend on how severe the early symptoms of congenital enterovirus infection were and which organs were involved. When effects do occur, they often reflect scarring or injury from the initial infection rather than ongoing virus activity.
Some children develop more slowly in speech, learning, or social skills. These differences may become clearer in preschool and primary school. Progress can continue over time, even if milestones arrive later.
Muscle stiffness or poor coordination can appear after early brain inflammation. In severe cases, long-term motor disability similar to cerebral palsy may occur. Effects can range from mild clumsiness to ongoing mobility needs.
Seizures that began during acute illness may recur later in childhood. This can lead to a diagnosis of epilepsy in some after congenital enterovirus infection. Others may have a single early seizure and never have another.
Newborn myocarditis can leave lasting weakness of the heart pump. Some develop dilated cardiomyopathy with fatigue or breathlessness on exertion. A few may have rhythm problems that persist.
How is it to live with Congenital enterovirus infection?
Living with congenital enterovirus infection can range from quiet recovery after a stressful start to life to ongoing medical needs, depending on which organs were affected and how severe the illness was. Some babies recover fully, while others may face challenges like feeding difficulties, developmental delays, or recurrent hospital visits for heart, liver, or nervous system follow-up; in those cases, families often become skilled at coordinating care and watching for early signs of infection or regression. Day to day, this can mean more appointments, strict hygiene around visitors, and careful planning for childcare, but many families find a rhythm with support from pediatric specialists, early intervention services, and their community. For loved ones, the biggest roles are patience, practical help, and staying alert to changes, all while celebrating progress—however small—as the child grows.
Treatment and drugs
Treatment for congenital enterovirus infection focuses on supportive care while the baby’s immune system fights the virus. In the hospital, this often includes IV fluids, careful feeding support, temperature control, and close monitoring of breathing, blood pressure, blood sugar, and organ function; some newborns need oxygen or a ventilator, medicines to support the heart, or treatment for seizures. If there’s concern for a bacterial infection at the same time, doctors may start antibiotics until tests rule bacteria out; antivirals like pleconaril aren’t routinely used, and intravenous immunoglobulin (IVIG) may be considered in severe cases, though evidence is mixed. Supportive care can make a real difference in how you feel day to day. After recovery, babies with severe congenital enterovirus infection may need follow‑up with pediatrics, cardiology, neurology, or liver specialists to track growth and development and address any lasting effects.
Non-drug treatment
For congenital enterovirus infection, care focuses on stabilizing your baby’s breathing, circulation, and feeding while the body fights the virus. Non-drug treatments often lay the foundation for recovery and help prevent complications. These supports are adjusted to your baby’s age and how severe the illness is, especially when early symptoms of congenital enterovirus infection appear in the first days of life. Your team will also plan follow-up to track growth, movement, hearing, and learning over time.
Continuous checks of heart rate, breathing, temperature, and blood sugar help catch changes early. Monitors and bedside exams guide when to step up or ease support. This close watch can reduce complications.
Extra oxygen or gentle ventilation keeps oxygen levels safe while the lungs heal. Positioning and suctioning help clear mucus and ease work of breathing.
IV fluids or tube feeds prevent dehydration and maintain energy for healing. Breast milk or formula is adjusted to what your baby can safely take.
Warmers or cooling blankets help keep body temperature steady. Stable temperature lowers stress on the heart, brain, and immune system.
Your genes may have an impact on how drugs work for you
Even when two newborns receive the same medicine for congenital enterovirus infection, their bodies can handle it differently because genes affect how drugs are absorbed, broken down, and cleared. Pharmacogenetic testing can sometimes guide dosing to improve benefits and reduce side effects.
Pharmacological treatments
Treatment focuses on supporting a newborn through the acute illness while targeting the virus or complications when possible. Because early symptoms of congenital enterovirus infection can look like bacterial sepsis, doctors often start medicines quickly while tests are pending. Not everyone responds to the same medication in the same way. Choices depend on the baby’s organs involved—brain, heart, liver—and how sick they are in the first hours to days.
Doctors may infuse IVIG to provide ready-made antibodies when infection is severe or spreading. It’s used most in serious heart, liver, or brain involvement, though benefits can vary.
Pleconaril or pocapavir may be considered under research or compassionate-use pathways in life-threatening cases. These drugs are not FDA- or EMA-approved and access is limited.
Ampicillin plus gentamicin or cefotaxime are often started until bacterial infection is ruled out. Antibiotics do not treat the virus itself but protect against missing a serious bacterial cause.
In myocarditis or heart failure, inotropes such as dopamine or milrinone can help the heart pump more effectively. Diuretics like furosemide may reduce fluid strain on the heart and lungs.
Genetic influences
Congenital enterovirus infection happens through exposure to the virus before, during, or soon after birth—not because the virus is inherited in your DNA. Still, your genes can shape how strongly a pregnant person and a newborn fight the virus, especially genes that guide the body’s first-line antiviral defenses and the ability to make protective antibodies. Genetics is only one piece of the puzzle, but it may help explain why one baby has a mild illness while another develops severe disease. Rare, inherited immune conditions—such as disorders that limit antibody production—can make congenital enterovirus infection more serious or long-lasting. A pregnant person’s prior exposure to a specific enterovirus and their genetic capacity to build and pass antibodies across the placenta can lower a newborn’s risk, whereas a lack of these antibodies can raise the chance of severe infection. Genetics does not change the early symptoms of congenital enterovirus infection; it mainly influences susceptibility and severity, and in unusually severe or persistent cases doctors may recommend genetic testing to look for underlying immune problems.
Is Congenital enterovirus infection genetic?
Genetics plays a limited role in congenital enterovirus infection. The virus causes the illness; inherited differences mainly influence how strongly the immune system responds. Rare immune gene variants can increase risk for severe disease, but most cases aren’t genetically driven.
Pharmacogenetics—how genetics influence drug effects
Treatment for congenital enterovirus infection often involves supportive care, and in some cases medicines such as intravenous immune globulin (IVIG) or antivirals being studied. How a newborn handles these drugs can vary from baby to baby. Genes can influence how quickly the liver and kidneys process medicines, which means one infant may break down a drug slowly while another clears it faster, so doctors may adjust the dose or timing accordingly. Not every difference in response is genetic, but illness severity, prematurity, organ function, and other medicines given at the same time also play a big role.
There isn’t a single genetic test that determines the treatment plan for congenital enterovirus infection right now. Still, when pharmacogenetic information is available, it may help reduce side effects or guide dosing for antivirals, pain relievers, or fever medicines used during care. Pharmacogenetics doesn’t change the early symptoms of congenital enterovirus infection, but it can help explain why one infant needs a lower dose while another needs closer monitoring. In practice, clinicians combine bedside signs, lab results, and—when appropriate—genetic information to personalize care and keep safety front and center.
Interactions with other conditions
In newborns, other health issues can change how severe congenital enterovirus infection becomes and how it shows up day to day. Doctors call it a “comorbidity” when two conditions occur together. Prematurity, congenital heart defects, or chronic lung disease can lower a baby’s reserve, so heart inflammation (myocarditis), breathing problems, or low blood pressure linked to the virus may hit harder and last longer. Early symptoms of congenital enterovirus infection—such as poor feeding, fever, or sleepiness—can look a lot like bacterial sepsis or other newborn infections (like herpes or cytomegalovirus), and coinfections sometimes occur, which can blur the picture and delay targeted treatment. Babies with very low antibody levels or inherited immune conditions are at higher risk for prolonged or severe disease; treatments that replace antibodies for those conditions can sometimes help the body control the virus. Liver or metabolic disorders may also compound the risk of bleeding or severe hepatitis, and medicines that dampen the immune system (for example, steroids used for other illnesses) may allow the virus to spread more easily, so teams weigh benefits and risks carefully.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described clusters of fever and rash in newborns that seemed different from illnesses in older children. Midwives and physicians noted that some babies struggled with feeding, became unusually sleepy, or developed sudden breathing or heart problems in the first days of life. Families and communities once noticed patterns of newborn illness appearing in late summer and early autumn, when stomach “bugs” and hand‑foot‑and‑mouth disease were also circulating, hinting at a seasonal link.
First described in the medical literature as severe neonatal sepsis without a clear bacterial cause, these early reports captured the urgency but not the origin. As medical science evolved, careful observation showed that some pregnant people had mild cold‑like symptoms before delivery, and their babies later developed serious infections of the brain, liver, or heart. Early hospital records also documented outbreaks in nurseries, suggesting that both pregnancy exposure and early contact after birth could play a role.
From early theories to modern research, the story of congenital enterovirus infection moved from patterns on paper to proof in the lab. In the 1960s and 1970s, researchers learned how to grow enteroviruses and track them during community outbreaks. This allowed doctors to connect a mother’s recent enterovirus illness during late pregnancy with infection found in the placenta, amniotic fluid, or a newborn’s blood and spinal fluid. Initially understood only through symptoms, later cases were confirmed with viral culture and, over time, with PCR testing that could detect tiny amounts of viral genetic material.
With each decade, the picture sharpened. Reports showed that congenital enterovirus infection can mimic bacterial sepsis, and that early symptoms of congenital enterovirus infection—poor feeding, lethargy, fever, or low temperature—often appear in the first week of life. Clinicians also recognized severe forms, including inflammation of the heart (myocarditis), liver failure, and brain infection, which helped explain why some babies suddenly became critically ill despite a healthy pregnancy and birth.
Advances in obstetric and neonatal care changed how these infections were managed. Routine use of maternal and newborn screening for other infections highlighted gaps for viruses without vaccines, like most enteroviruses. Polymerase chain reaction testing, widely adopted in the 1990s and 2000s, allowed faster diagnosis from blood, cerebrospinal fluid, or throat and stool samples, reducing unnecessary antibiotics when results pointed to a viral cause.
In recent decades, awareness has grown that congenital enterovirus infection is likely underrecognized because symptoms can be nonspecific and because testing is not always done. Seasonal surveillance and modern neonatal intensive care have improved outcomes for many babies, especially when teams act quickly with supportive care and close monitoring of the heart, liver, and brain. Understanding this history helps explain today’s recommendations: consider enterovirus during peak seasons, test when newborns become ill without a clear source, and provide prompt supportive treatment while results are pending.